In-vitro and in-silico analysis shows antibiofilm effects of a graphene oxide-silver nanocomposite, indicating potential for infection control.
Biofilm-related infections contribute to 65-80% of all human microbial infections, leading to significant mortality and morbidity. They also have significant non-medical industrial impact, including fouling of ship hulls, clogging water...
No takes yet. Share an insight, caveat, or question.
Khan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: